OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0000815094

ABIOMED INC

ABIOMED INC (CIK 0000815094, EIN 04-2743260) reported revenue of $1.03 billion ($1,031,753,000) for FY2022 (2021-04-01 to 2022-03-31) and net income of $136.51 million ($136,505,000) for FY2022 (2021-04-01 to 2022-03-31), as filed in its 10-K filed 2022-05-20 (accession 0000950170-22-010402).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends March 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0000815094
EIN04-2743260
SIC industry code3841 Surgical & Medical Instruments & Apparatus
State or country of incorporationDE
Fiscal year endMarch 31
Filer categoryLarge accelerated filer
Entity typeoperating
Olympus entity IDorg_67w4ft5k41vpf77rqtk29yfvxf
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$1,031,753,000FY20222021-04-01 to 2022-03-3110-K2022-05-200000950170-22-010402RevenueFromContractWithCustomerExcludingAssessedTax
Net income$136,505,000FY20222021-04-01 to 2022-03-3110-K2022-05-200000950170-22-010402NetIncomeLoss
Total assets$1,673,393,000FY2022as of 2022-03-3110-K2022-05-200000950170-22-010402Assets
Total liabilities$170,067,000FY2022as of 2022-03-3110-K2022-05-200000950170-22-010402Liabilities
Stockholders' equity$1,503,326,000FY2022as of 2022-03-3110-K2022-05-200000950170-22-010402StockholdersEquity
Operating cash flow$285,390,000FY20222021-04-01 to 2022-03-3110-K2022-05-200000950170-22-010402NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share$2.98 per shareFY20222021-04-01 to 2022-03-3110-K2022-05-200000950170-22-010402EarningsPerShareDiluted
Shares outstanding45,563,937 sharesFY2022as of 2022-05-1210-K2022-05-200000950170-22-010402EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2013-2022, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20222021-04-01 to 2022-03-31$1,031,753,00010-K2022-05-200000950170-22-010402
RevenueFY20212020-04-01 to 2021-03-31$847,522,00010-K2022-05-200000950170-22-010402
RevenueFY20202019-04-01 to 2020-03-31$840,883,00010-K2022-05-200000950170-22-010402
RevenueFY20192018-04-01 to 2019-03-31$769,432,00010-K2021-05-210001564590-21-029314
RevenueFY20182017-04-01 to 2018-03-31$593,749,00010-K2018-05-240001564590-18-014310
RevenueFY20172016-04-01 to 2017-03-31$445,304,00010-K2018-05-240001564590-18-014310
RevenueFY20162015-04-01 to 2016-03-31$329,543,00010-K2018-05-240001564590-18-014310
RevenueFY20152014-04-01 to 2015-03-31$230,311,00010-K2017-05-250001564590-17-011690
RevenueFY20132013-04-01 to 2014-03-31$183,643,00010-K2016-05-260001564590-16-020014
Net incomeFY20222021-04-01 to 2022-03-31$136,505,00010-K2022-05-200000950170-22-010402
Net incomeFY20212020-04-01 to 2021-03-31$225,525,00010-K2022-05-200000950170-22-010402
Net incomeFY20202019-04-01 to 2020-03-31$203,009,00010-K2022-05-200000950170-22-010402
Net incomeFY20192018-04-01 to 2019-03-31$259,016,00010-K2021-05-210001564590-21-029314
Net incomeFY20182017-04-01 to 2018-03-31$112,170,00010-K2020-05-210001564590-20-026547
Net incomeFY20172016-04-01 to 2017-03-31$52,116,00010-K2019-05-230001564590-19-020329
Net incomeFY20162015-04-01 to 2016-03-31$38,147,00010-K2018-05-240001564590-18-014310
Net incomeFY20152014-04-01 to 2015-03-31$113,688,00010-K2017-05-250001564590-17-011690
Net incomeFY20132013-04-01 to 2014-03-31$7,351,00010-K2016-05-260001564590-16-020014

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2022-11-032022-09-300000950170-22-021880abmd-20220930.htm
10-Q2022-08-042022-06-300000950170-22-014795abmd-20220630.htm
10-K2022-05-202022-03-310000950170-22-010402abmd-20220331.htm
10-Q2022-02-032021-12-310001564590-22-003810abmd-10q_20211231.htm
10-Q2021-10-282021-09-300001564590-21-052645abmd-10q_20210930.htm
10-Q2021-08-052021-06-300001564590-21-041562abmd-10q_20210630.htm
10-K2021-05-212021-03-310001564590-21-029314abmd-10k_20210331.htm
10-Q2021-02-042020-12-310001564590-21-004306abmd-10q_20201231.htm
10-Q2020-11-062020-09-300001564590-20-051944abmd-10q_20200930.htm
10-Q2020-08-062020-06-300001564590-20-037706abmd-10q_20200630.htm
10-K2020-05-212020-03-310001564590-20-026547abmd-10k_20200331.htm
10-Q2020-02-062019-12-310001564590-20-003682abmd-10q_20191231.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0000815094published by the sourcedata.sec.gov/submissions/CIK0000815094.json2026-10-21
Employer Identification Number (EIN) · US-EIN04-2743260published by the sourcedata.sec.gov/submissions/CIK0000815094.json2026-10-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0000815094.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0000815094.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000815094" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000815094/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0000815094/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"815094"}

On SEC EDGAR

About this data